DEXIRON 50 MG
IRON (IRON DEXTRAN COMPLEX) : 50 MG · DIN 02205963 · AMERICAN REGENT, INC
Health Canada status: CANCELLED POST MARKET
What is DEXIRON?
DEXIRON 50 MG contains IRON (IRON DEXTRAN COMPLEX) : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 02205963, held by AMERICAN REGENT, INC, supplied as SOLUTION for INTRAMUSCULAR ; INTRAVENOUS administration. Health Canada currently lists it as cancelled post market, status dated 12-May-2022. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is DEXIRON used for?
Treatment of documented iron deficiency in patients in whom oral iron administration is unsatisfactory or impossible.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02205963 |
|---|---|
| Brand name | DEXIRON |
| Generic / active ingredient | IRON (IRON DEXTRAN COMPLEX) : 50 MG |
| Manufacturer | AMERICAN REGENT, INC |
| Strength | 50 MG |
| Dosage form | SOLUTION |
| Route of administration | INTRAMUSCULAR ; INTRAVENOUS |
| Schedule | Prescription |
| ATC code | B03AC IRON, PARENTERAL PREPARATIONS |
| AHFS class | 20:04.04 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 12-May-2022 |
| Original market date | 1996-09-06 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02205963 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2205963 |
| Brand name | DEXIRON |
| Active ingredient / INN | IRON (IRON DEXTRAN COMPLEX) : 50 MG |
| ATC code | B03AC |
| ATC anatomical main group | B — Blood and blood-forming organs |
| ATC therapeutic subgroup | B03 |
| AHFS class | 20:04.04 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | AMERICAN REGENT, INC |
How is it administered?
Discontinue oral iron. Administer 0.5 mL test dose first. IV: slow rate (max 1 mL/min). IM: Z-track technique into upper outer quadrant of buttock. Daily dose usually max 2 mL.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store at room temperature, 15°-30°C (59°-86°F). Protect from excessive heat. Do not freeze.
How is it supplied?
2 mL single-dose vials supplied in cartons of 10 vials.
Which pack is which?
| Strength on the label | 50 MG |
|---|---|
| Dosage form | SOLUTION |
| Route | INTRAMUSCULAR ; INTRAVENOUS |
| Packaging as described in the monograph | 2 mL single-dose vials supplied in cartons of 10 vials. |
| Storage | Store at room temperature, 15°-30°C (59°-86°F). Protect from excessive heat. Do not freeze. |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Contraindications
Hypersensitivity to the drug product. All anemias not associated with iron deficiency.
Warnings and precautions
Serious hypersensitivity/fatal anaphylactic reactions reported. Use only where resuscitative equipment is available. Risk of injection site carcinogenesis. Avoid Total Dose Infusion (TDI).
What can be used instead?
Other Canadian products sharing ATC code B03AC IRON, PARENTERAL PREPARATIONS. 5 of 10 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| FERINJECT | 50 MG | DISPERSION | VIFOR (INTERNATIONAL) INC. | MARKETED | DIN 02546078 |
| FERRLECIT | 12.5 MG | SOLUTION | SANOFI-AVENTIS CANADA INC | MARKETED | DIN 02243333 |
| MONOFERRIC | 100 MG | SOLUTION | Pfizer Canada Ulc | MARKETED | DIN 02477777 |
| PMS-IRON SUCROSE | 20 MG | SOLUTION | PHARMASCIENCE INC | MARKETED | DIN 02502917 |
| VENOFER | 20 MG | SOLUTION | FRESENIUS MEDICAL CARE CAN INC | MARKETED | DIN 02243716 |
| FERAHEME | 30 MG | SOLUTION | AMAG PHARMACEUTICALS INC | CANCELLED POST MARKET | DIN 02377217 |
| INFUFER | 50 MG | LIQUID | SANDOZ CANADA INCORPORATED | CANCELLED POST MARKET | DIN 02221780 |
| JECTOFER 50 MG/ML | 100 MG | LIQUID | ASTRAZENECA CANADA INC | CANCELLED POST MARKET | DIN 00001910 |
| TRIFERIC AVNU | 1.5 MG | SOLUTION | ROCKWELL MEDICAL INC | CANCELLED PRE MARKET | DIN 02515334 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.